Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JI1S
|
|||
| Former ID |
DIB001287
|
|||
| Drug Name |
RDEA-640
|
|||
| Synonyms |
RDEA-800; RDEA-900; VRX-480773; VRX-840773; NNRTIs (HIV infection), Ardea; NNRTIs (HIV infection), Valeant; Non-nucleoside reverse transcriptase inhibitor 800 series (HIV infection), Ardea; Non-nucleoside reverse transcriptase inhibitor 900 series (HIV infection), Ardea; Non-nucleoside reverse transcriptase inhibitors (HIV infection), Ardea; Non-nucleoside reverse transcriptase inhibitors (HIV infection), Valeant
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Terminated | [1] | |
| Company |
Valeant Pharmaceuticals International Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Reverse transcriptase (HIV RT) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024208) | |||
| REF 2 | WO patent application no. 2008,0165,22, Novel hiv reverse transcriptase inhibitors. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.